Non-Genomic Actions of the Androgen Receptor in Prostate Cancer

about

AR Signaling and the PI3K Pathway in Prostate Cancer Sex Steroids, Adult Neurogenesis, and Inflammation in CNS Homeostasis, Degeneration, and Repair.A network of epigenomic and transcriptional cooperation encompassing an epigenomic master regulator in cancer.

P2860

Q39249001-8FE5CEFC-7AB8-4152-8E4F-4324B7A7DA50 Q55420696-DC6BA29A-702E-4C7C-B97C-9B3B0F528046 Q55516237-EA008EBC-8BF9-4C65-90FC-30949D435C5F

P2860

Non-Genomic Actions of the Androgen Receptor in Prostate Cancer

Item

http://www.wikidata.org/entity/Q37588620

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 17 January 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Non-Genomic Actions of the Androgen Receptor in Prostate Cancer

@en

Non-Genomic Actions of the Androgen Receptor in Prostate Cancer.

@nl

type

Item

label

Non-Genomic Actions of the Androgen Receptor in Prostate Cancer

@en

Non-Genomic Actions of the Androgen Receptor in Prostate Cancer.

@nl

prefLabel

Non-Genomic Actions of the Androgen Receptor in Prostate Cancer

@en

Non-Genomic Actions of the Androgen Receptor in Prostate Cancer.

@nl

P1476

Non-Genomic Actions of the Androgen Receptor in Prostate Cancer

@en

P2093

Jacky K Leung

http://www.w3.org/2001/XMLSchema#string

P2860

Regression of castrate-recurrent prostate cancer by a small-molecule inhibitor of the amino-terminus domain of the androgen receptor

Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation

Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor

Evidence-based recommendations on androgen deprivation therapy for localized and advanced prostate cancer

Androgen receptor activation in castration-recurrent prostate cancer: the role of Src-family and Ack1 tyrosine kinases

A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth

Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms

Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways

Ligand-independent activation of the androgen receptor by interleukin-6 and the role of steroid receptor coactivator-1 in prostate cancer cells

Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FENDO.2017.00002

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

M D Sadar

P577

2017-01-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28144231

http://www.w3.org/2001/XMLSchema#string

P932

5239799

http://www.w3.org/2001/XMLSchema#string

Non-Genomic Actions of the Androgen Receptor in Prostate Cancer

about

P2860

P2860

Non-Genomic Actions of the Androgen Receptor in Prostate Cancer

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932